Ever since President Bush (the First) declared the 1990s to be the Decade of the Brain, hopes have been high for device innovations to treat a variety of neurological conditions ranging from stroke to migraines to depression. For all the promise these therapeutic areas hold, however, neurological device applications have proven to be among the most inscrutable for entrepreneurs and investors, replete with technological and clinical challenges.
Several recent announcements have done nothing but confirm how challenging the neuro space is. In fact, this year is starting out to be one that neuro investors would just as...